BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ichikawa W. Prediction of clinical outcome of fluoropyrimidine-based chemotherapy for gastric cancer patients, in terms of the 5-fluorouracil metabolic pathway. Gastric Cancer. 2006;9:145-155. [PMID: 16952032 DOI: 10.1007/s10120-006-0373-8] [Cited by in Crossref: 42] [Cited by in F6Publishing: 41] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Fernandez KS, Baum R, Fung B, Yeager N, Leonis MA, Wagner LM, Tiao G, Ross ME. Chemoresistant hepatoblastoma in a patient with mosaic trisomy 18 treated with orthotopic liver transplantation: Hepatoblastoma and Trisomy 18. Pediatr Blood Cancer 2011;56:498-500. [DOI: 10.1002/pbc.22768] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
2 Valente M, Vidal AE, González Pacanowska D. Potential of Pyrimidine Metabolism for Antitrypanosomal Drug Discovery. In: Müller S, Cerdan R, Radulescu O, editors. Comprehensive Analysis of Parasite Biology: From Metabolism to Drug Discovery. Weinheim: Wiley-VCH Verlag GmbH & Co. KGaA; 2016. pp. 147-70. [DOI: 10.1002/9783527694082.ch6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
3 Naruke A, Azuma M, Takeuchi A, Ishido K, Katada C, Sasaki T, Higuchi K, Tanabe S, Saegusa M, Koizumi W. Comparison of site-specific gene expression levels in primary tumors and synchronous lymph node metastases in advanced gastric cancer. Gastric Cancer 2015;18:262-70. [PMID: 24651981 DOI: 10.1007/s10120-014-0357-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
4 Villela AD, Ducati RG, Rosado LA, Bloch CJ, Prates MV, Gonçalves DC, Ramos CH, Basso LA, Santos DS. Biochemical characterization of uracil phosphoribosyltransferase from Mycobacterium tuberculosis. PLoS One 2013;8:e56445. [PMID: 23424660 DOI: 10.1371/journal.pone.0056445] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
5 Koizumi W, Tanabe S, Azuma M, Ishido K, Nishimura K, Sasaki T, Nakatani K, Higuchi K, Nakayama N, Katada C. Impacts of fluorouracil-metabolizing enzymes on the outcomes of patients treated with S-1 alone or S-1 plus cisplatin for first-line treatment of advanced gastric cancer. Int J Cancer. 2010;126:162-170. [PMID: 19588501 DOI: 10.1002/ijc.24726] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 1.8] [Reference Citation Analysis]
6 Luzina EL, Popov AV. Synthesis and anticancer activity of N-bis(trifluoromethyl)alkyl-N'-thiazolyl and N-bis(trifluoromethyl)alkyl-N'-benzothiazolyl ureas. Eur J Med Chem 2009;44:4944-53. [PMID: 19740574 DOI: 10.1016/j.ejmech.2009.08.007] [Cited by in Crossref: 60] [Cited by in F6Publishing: 44] [Article Influence: 5.0] [Reference Citation Analysis]
7 Okamura Y, Yasukawa S, Narimatsu H, Boku N, Fukutomi A, Konishi M, Morinaga S, Toyama H, Kaneoka Y, Shimizu Y, Nakamori S, Sata N, Yamakita K, Takahashi A, Kainuma O, Hishinuma S, Yamaguchi R, Nagino M, Hirano S, Yanagisawa A, Mori K, Uesaka K. Human equilibrative nucleoside transporter-1 expression is a predictor in patients with resected pancreatic cancer treated with adjuvant S-1 chemotherapy. Cancer Sci 2020;111:548-60. [PMID: 31778273 DOI: 10.1111/cas.14258] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
8 Luzina EL, Popov AV. Synthesis, evaluation of anticancer activity and COMPARE analysis of N-bis(trifluoromethyl)alkyl-N'-substituted ureas with pharmacophoric moieties. Eur J Med Chem 2012;53:364-73. [PMID: 22538016 DOI: 10.1016/j.ejmech.2012.03.026] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 2.8] [Reference Citation Analysis]
9 Yeh CN, Jung SM, Chen TW, Hwang TL, Jan YY, Chen MF. Expression of thymidylate synthase determines the response of gastric cancer patients undergoing gastrectomy to 5-fluorouracil-based adjuvant chemotherapy. Langenbecks Arch Surg. 2010;395:217-225. [PMID: 20012317 DOI: 10.1007/s00423-009-0573-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
10 Huang ZH, Hua D, Li LH, Zhu JD. Prognostic role of p53 codon 72 polymorphism in gastric cancer patients treated with fluorouracil-based adjuvant chemotherapy. J Cancer Res Clin Oncol. 2008;134:1129-1134. [PMID: 18357466 DOI: 10.1007/s00432-008-0380-8] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
11 Miwa T, Kanda M, Tanaka C, Kobayashi D, Hayashi M, Yamada S, Nakayama G, Koike M, Kodera Y. Albumin-Bilirubin Score Predicts Tolerability to Adjuvant S-1 Monotherapy after Curative Gastrectomy. J Gastric Cancer 2019;19:183-92. [PMID: 31245163 DOI: 10.5230/jgc.2019.19.e15] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Wang Z, Chen JQ, Liu JL, Qin XG, Huang Y. Polymorphisms in ERCC1, GSTs, TS and MTHFR predict clinical outcomes of gastric cancer patients treated with platinum/5-Fu-based chemotherapy: a systematic review. BMC Gastroenterol. 2012;12:137. [PMID: 23020798 DOI: 10.1186/1471-230x-12-137] [Cited by in Crossref: 30] [Cited by in F6Publishing: 20] [Article Influence: 3.3] [Reference Citation Analysis]
13 Amin LH, Shawer TZ, El-naggar AM, El-sehrawi HM. Design, synthesis, anticancer evaluation and docking studies of new pyrimidine derivatives as potent thymidylate synthase inhibitors. Bioorganic Chemistry 2019;91:103159. [DOI: 10.1016/j.bioorg.2019.103159] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
14 Gao J, Lu M, Yu JW, Li YY, Shen L. Thymidine Phosphorylase/β-tubulin III expressions predict the response in Chinese advanced gastric cancer patients receiving first-line capecitabine plus paclitaxel. BMC Cancer 2011;11:177. [PMID: 21586171 DOI: 10.1186/1471-2407-11-177] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 1.8] [Reference Citation Analysis]
15 Sasako M, Terashima M, Ichikawa W, Ochiai A, Kitada K, Kurahashi I, Sakuramoto S, Katai H, Sano T, Imamura H. Impact of the expression of thymidylate synthase and dihydropyrimidine dehydrogenase genes on survival in stage II/III gastric cancer. Gastric Cancer 2015;18:538-48. [PMID: 25112781 DOI: 10.1007/s10120-014-0413-8] [Cited by in Crossref: 26] [Cited by in F6Publishing: 31] [Article Influence: 3.7] [Reference Citation Analysis]
16 Ishido K, Azuma M, Koizumi W, Takeuchi A, Sakuramoto S, Watanabe M, Okayasu I. Evaluation of prognostic factors for the response to S-1 in patients with stage II or III advanced gastric cancer who underwent gastrectomy. Pharmacogenet Genomics. 2009;19:955-964. [PMID: 19898266 DOI: 10.1097/fpc.0b013e328333351b] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
17 Xie H, Wang W, Sun F, Deng K, Lu X, Liu H, Zhao W, Zhang Y, Zhou X, Li K, Hou Y. Proteomics analysis to reveal biological pathways and predictive proteins in the survival of high-grade serous ovarian cancer. Sci Rep 2017;7:9896. [PMID: 28852147 DOI: 10.1038/s41598-017-10559-9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
18 Wang X, Yan SK, Dai WX, Liu XR, Zhang WD, Wang JJ. A metabonomic approach to chemosensitivity prediction of cisplatin plus 5-fluorouracil in a human xenograft model of gastric cancer. Int J Cancer. 2010;127:2841-2850. [PMID: 21351263 DOI: 10.1002/ijc.25294] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
19 Nakamura A, Hayashi K, Nakajima G, Kamikozuru H, Okuyama R, Kuramochi H, Hatori T, Yamamoto M. Impact of dihydropyrimidine dehydrogenase and γ-glutamyl hydrolase on the outcomes of patients treated with gemcitabine or S-1 as adjuvant chemotherapy for advanced pancreatic cancer. Exp Ther Med 2011;2:1097-103. [PMID: 22977627 DOI: 10.3892/etm.2011.340] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
20 Han R, Yang YM, Dietrich J, Luebke A, Mayer-Pröschel M, Noble M. Systemic 5-fluorouracil treatment causes a syndrome of delayed myelin destruction in the central nervous system. J Biol 2008;7:12. [PMID: 18430259 DOI: 10.1186/jbiol69] [Cited by in Crossref: 181] [Cited by in F6Publishing: 153] [Article Influence: 13.9] [Reference Citation Analysis]
21 Pereira MA, Ramos MFKP, Dias AR, Faraj SF, Cirqueira CDS, de Mello ES, Zilberstein B, Alves VAF, Ribeiro U Jr. Immunohistochemical expression of thymidylate synthase and prognosis in gastric cancer patients submitted to fluoropyrimidine-based chemotherapy. Chin J Cancer Res 2018;30:526-36. [PMID: 30510364 DOI: 10.21147/j.issn.1000-9604.2018.05.06] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
22 Nakamura J, Tanaka T, Kitajima Y, Noshiro H, Miyazaki K. Methylation-mediated gene silencing as biomarkers of gastric cancer: A review. World J Gastroenterol 2014; 20(34): 11991-12006 [PMID: 25232236 DOI: 10.3748/wjg.v20.i34.11991] [Cited by in CrossRef: 31] [Cited by in F6Publishing: 33] [Article Influence: 4.4] [Reference Citation Analysis]
23 Yan S, Nagle DG, Zhou Y, Zhang W. Application of Systems Biology in the Research of TCM Formulae. Systems Biology and its Application in TCM Formulas Research. Elsevier; 2018. pp. 31-67. [DOI: 10.1016/b978-0-12-812744-5.00003-5] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
24 Zhao HY, Huang H, Hu ZH, Huang Y, Lin SX, Tian Y, Lin TY. Evaluations of biomarkers associated with sensitivity to 5-fluorouracil and taxanes for recurrent/advanced breast cancer patients treated with capecitabine-based first-line chemotherapy. Anticancer Drugs 2012;23:534-42. [PMID: 22481060 DOI: 10.1097/CAD.0b013e32834f7ef4] [Cited by in Crossref: 12] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
25 Matsubara J, Nishina T, Yamada Y, Moriwaki T, Shimoda T, Kajiwara T, Nakajima TE, Kato K, Hamaguchi T, Shimada Y. Impacts of excision repair cross-complementing gene 1 (ERCC1), dihydropyrimidine dehydrogenase, and epidermal growth factor receptor on the outcomes of patients with advanced gastric cancer. Br J Cancer. 2008;98:832-839. [PMID: 18231104 DOI: 10.1038/sj.bjc.6604211] [Cited by in Crossref: 73] [Cited by in F6Publishing: 69] [Article Influence: 5.6] [Reference Citation Analysis]
26 Amioka A, Kadoya T, Sueoka S, Kobayashi Y, Sasada S, Emi A, Masumoto N, Ito M, Nakayama K, Okada M. Effect of Wnt5a on drug resistance in estrogen receptor-positive breast cancer. Breast Cancer 2021;28:1062-71. [PMID: 34047951 DOI: 10.1007/s12282-021-01241-0] [Reference Citation Analysis]
27 Cui YH, Liu TS, Zhuang RY, Gao HJ, Li H. Polymorphism of thymidylate synthase gene and chemosensitivity of 5-fluorouracil regimen in metastatic gastrointestinal cancer. J Dig Dis. 2009;10:118-123. [PMID: 19426394 DOI: 10.1111/j.1751-2980.2009.00373.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.2] [Reference Citation Analysis]
28 Yan SK, Liu RH, Jin HZ, Liu XR, Ye J, Shan L, Zhang WD. "Omics" in pharmaceutical research: overview, applications, challenges, and future perspectives. Chin J Nat Med 2015;13:3-21. [PMID: 25660284 DOI: 10.1016/S1875-5364(15)60002-4] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
29 Terashima M, Ichikawa W, Ochiai A, Kitada K, Kurahashi I, Sakuramoto S, Katai H, Sano T, Imamura H, Sasako M; ACTS-GC Group. TOP2A, GGH, and PECAM1 are associated with hematogenous, lymph node, and peritoneal recurrence in stage II/III gastric cancer patients enrolled in the ACTS-GC study. Oncotarget 2017;8:57574-82. [PMID: 28915696 DOI: 10.18632/oncotarget.15895] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
30 Ichikawa W, Terashima M, Ochiai A, Kitada K, Kurahashi I, Sakuramoto S, Katai H, Sano T, Imamura H, Sasako M. Impact of insulin-like growth factor-1 receptor and amphiregulin expression on survival in patients with stage II/III gastric cancer enrolled in the Adjuvant Chemotherapy Trial of S-1 for Gastric Cancer. Gastric Cancer 2017;20:263-73. [PMID: 26884344 DOI: 10.1007/s10120-016-0600-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
31 马延磊, 秦环龙. 代谢组学及其在肿瘤生物学研究中的应用进展. 世界华人消化杂志 2008; 16(34): 3877-3883 [DOI: 10.11569/wcjd.v16.i34.3877] [Reference Citation Analysis]
32 Ma Y, Zhang P, Yang Y, Wang F, Qin H. Metabolomics in the fields of oncology: a review of recent research. Mol Biol Rep 2012;39:7505-11. [PMID: 22350159 DOI: 10.1007/s11033-012-1584-1] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 2.3] [Reference Citation Analysis]
33 Komori S, Osada S, Mori R, Matsui S, Sanada Y, Tomita H, Tokuyama Y, Takahashi T, Yamaguchi K, Yoshida K. Contribution of thymidylate synthase to gemcitabine therapy for advanced pancreatic cancer. Pancreas 2010;39:1284-92. [PMID: 20944490 DOI: 10.1097/MPA.0b013e3181dec17d] [Cited by in Crossref: 23] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
34 Kristensen M, Pedersen P, Melsen G, Ellehauge J, Mejer J. Variants in the Dihydropyrimidine Dehydrogenase, Methylenetetrahydrofolate Reductase and Thymidylate Synthase Genes Predict Early Toxicity of 5-Fluorouracil in Colorectal Cancer Patients. J Int Med Res 2010;38:870-83. [DOI: 10.1177/147323001003800313] [Cited by in Crossref: 38] [Cited by in F6Publishing: 36] [Article Influence: 3.5] [Reference Citation Analysis]
35 Tang C, Yu S, Jiang H, Li W, Xu X, Cheng X, Peng K, Chen E, Cui Y, Liu T. A Meta-Analysis: Methylenetetrahydrofolate Reductase C677T Polymorphism in Gastric Cancer Patients Treated with 5-Fu Based Chemotherapy Predicts Serious Hematologic Toxicity but Not Prognosis. J Cancer 2018;9:1057-66. [PMID: 29581785 DOI: 10.7150/jca.23391] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
36 Hua D, Huang ZH, Mao Y, Deng JZ. Thymidylate synthase and thymidine phosphorylase gene expression as predictive parameters for the efficacy of 5-fluorouraci-based adjuvant chemotherapy for gastric cancer. World J Gastroenterol 2007; 13(37): 5030-5034 [PMID: 17854149 DOI: 10.3748/wjg.v13.i37.5030] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.1] [Reference Citation Analysis]
37 Zhang C, Liu H, Ma B, Song Y, Gao P, Xu Y, Yu D, Wang Z. The Impact of the Expression Level of Intratumoral Dihydropyrimidine Dehydrogenase on Chemotherapy Sensitivity and Survival of Patients in Gastric Cancer: A Meta-Analysis. Dis Markers 2017;2017:9202676. [PMID: 28255193 DOI: 10.1155/2017/9202676] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
38 Ichikawa W, Sasaki Y. Challenges in predicting the clinical outcome in S-1-based chemotherapy for gastric cancer patients. Int J Clin Oncol 2008;13:206-11. [DOI: 10.1007/s10147-008-0786-y] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
39 Wittmann JG, Heinrich D, Gasow K, Frey A, Diederichsen U, Rudolph MG. Structures of the human orotidine-5'-monophosphate decarboxylase support a covalent mechanism and provide a framework for drug design. Structure 2008;16:82-92. [PMID: 18184586 DOI: 10.1016/j.str.2007.10.020] [Cited by in Crossref: 35] [Cited by in F6Publishing: 29] [Article Influence: 2.7] [Reference Citation Analysis]
40 Nakamura K, Hatakeyama K, Furukawa K, Fujiya K, Kamiya S, Hikage M, Tanizawa Y, Bando E, Ohshima K, Urakami K, Machida N, Yasui H, Yamaguchi K, Terashima M. Prediction of S-1 adjuvant chemotherapy benefit in Stage II/III gastric cancer treatment based on comprehensive gene expression analysis. Gastric Cancer 2020;23:648-58. [PMID: 32185558 DOI: 10.1007/s10120-020-01056-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
41 Breda A, Machado P, Rosado LA, Souto AA, Santos DS, Basso LA. Pyrimidin-2(1H)-ones based inhibitors of Mycobacterium tuberculosis orotate phosphoribosyltransferase. Eur J Med Chem 2012;54:113-22. [PMID: 22608674 DOI: 10.1016/j.ejmech.2012.04.031] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]